HOME >> BIOLOGY >> NEWS
Gene therapy with growth factor seems promising therapy for incurable muscle disorder ALS

ALS is an incurable paralysing muscle disorder affecting five in every one hundred thousand people. The disease mainly strikes healthy people in the most active period of their life, without any warning or family history. Researchers from VIB (the Flanders Interuniversity Institute for Biotechnology), lead by Prof. Peter Carmeliet (K.U.Leuven) already indicated the importance of the VEGF protein in this illness, on the basis of genetic studies. In cooperation with Oxford BioMedica, an Oxford-based biotech company, a new study of the VIB researchers indicates that gene therapy with VEGF appears to be one of the most promising therapies. By administering the gene that produces VEGF in the nerve trajectory of ALS mice, the researchers were able to slow down the development of the illness and increase their life expectancy by 30% - the largest therapeutic effect ever achieved for ALS.

ALS can affect anyone. Chinese leader Mao Tse Tung, Russian composer Dimitri Sjostakowitz, legendary Yankee baseball player Lou Gehrig and astrophysicist Stephen Hawkins were all affected by ALS. A large number of Italian top football players, pilots and soldiers in the Gulf War were also affected by this fatal disease. Around half of them die within three years, some even within a year, mostly in full possession of their faculties as a result of asphyxiation.

In patients with Amyotrophic Lateral Sclerosis (ALS) the nerves going to the muscles deteriorate, which is why the patient loses control of his muscles and is progressively paralysed, but remains disconcertingly in full possession of his faculties. The cause of this serious deterioration disease with an enormous clinico-social impact remains obscure. Up to now the disease was completely untreatable, because of which many ALS patients opt for euthanasia, a very controversial solution. Previously, genetic research by Peter Carmeliet and his team at K.U.Leuven has already led to the surprising insight that the vascular
'"/>

Contact: Ann Van Gysel
ann.vangysel@vib.be
32-9-244-66-11
VIB, Flanders Interuniversity Institute of Biotechnology
27-May-2004


Page: 1 2 3

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2018)... Va. (PRWEB) , ... November 07, 2018 , ... ... market research and advisory firm serving the life science industry. The event was ... “tools of science” that advance biological research and drug discovery. The winners were ...
(Date:11/6/2018)... ... November 06, 2018 , ... Genedata, a leading ... Cellca GmbH, a subsidiary of Sartorius Stedim Biotech (SSB) and a specialist for ... Genedata Bioprocess ® enterprise platform to be used at SSB laboratories in ...
(Date:11/3/2018)... (PRWEB) , ... November 01, 2018 , ... Karius ... researchers using next-generation sequencing to study human pathogens in pediatric patients. One grant of ... of the Karius cell-free DNA test for infectious diseases. In addition to the funding, ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... 2018 , ... GlycoMark, Inc., the exclusive provider of the ... http://www.glycomark.com , as part of National Diabetes Month. The new complimentary ... in November from 9 a.m. – 5 p.m. ET weekdays for healthcare professionals ...
(Date:11/3/2018)... ... November 01, 2018 , ... ... Summit. Dr. Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA ... and ensure data reliability. , What should clinical research industry stakeholders keep in ...
(Date:10/31/2018)... ... October 30, 2018 , ... Rooam , the premier payment platform ... this winter. After its acquisition of the Tally payment app, the leading payment platform ... tips, Rooam will grow its market share and increase the number of restaurant and ...
(Date:10/31/2018)... ... ... Pippa Rose is a young Labrador retriever. Like most labs, Pippa is energetic, crazy, ... to the cruciate ligament in her right knee. According to her mom, Kinsley, Pippa ... that it broke her heart to see Pippa lie around in pain because it hurt ...
Breaking Biology Technology:
Cached News: